
New Pill Doubles Survival for Pancreatic Cancer Patients
A recently approved medication is extending life expectancy for pancreatic cancer patients whose disease persisted after chemotherapy, offering new hope for one of the deadliest forms of cancer. The drug works by targeting a protein previously thought impossible to reach pharmaceutically.
















